PFS Investments’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $2.99M | Buy |
72,791
+15
| +0% | +$616 | 0.05% | 286 |
|
2023
Q1 | $2.71M | Buy |
72,776
+651
| +0.9% | +$24.3K | 0.05% | 276 |
|
2022
Q4 | $2.72M | Sell |
72,125
-3,077
| -4% | -$116K | 0.05% | 258 |
|
2022
Q3 | $3.33K | Buy |
75,202
+1,077
| +1% | +$48 | 0.06% | 217 |
|
2022
Q2 | $2.74M | Sell |
74,125
-936
| -1% | -$34.6K | 0.06% | 243 |
|
2022
Q1 | $2.78M | Sell |
75,061
-1,118
| -1% | -$41.4K | 0.05% | 253 |
|
2021
Q4 | $2.32M | Sell |
76,179
-663
| -0.9% | -$20.2K | 0.04% | 265 |
|
2021
Q3 | $2.68M | Buy |
76,842
+1,127
| +1% | +$39.3K | 0.06% | 237 |
|
2021
Q2 | $2.94M | Buy |
75,715
+5,211
| +7% | +$203K | 0.07% | 217 |
|
2021
Q1 | $3.17M | Buy |
70,504
+13,330
| +23% | +$599K | 0.08% | 197 |
|
2020
Q4 | $3.55M | Buy |
57,174
+8,648
| +18% | +$537K | 0.1% | 169 |
|
2020
Q3 | $2.3M | Buy |
48,526
+6,135
| +14% | +$291K | 0.08% | 180 |
|
2020
Q2 | $2.5M | Buy |
42,391
+6,228
| +17% | +$367K | 0.09% | 149 |
|
2020
Q1 | $1.71M | Buy |
36,163
+7,883
| +28% | +$373K | 0.07% | 159 |
|
2019
Q4 | $1.71M | Buy |
28,280
+3,908
| +16% | +$236K | 0.07% | 155 |
|
2019
Q3 | $1.46M | Buy |
24,372
+8,728
| +56% | +$523K | 0.06% | 129 |
|
2019
Q2 | $1.01M | Buy |
15,644
+10,573
| +208% | +$683K | 0.05% | 130 |
|
2019
Q1 | $412K | Buy |
+5,071
| New | +$412K | 0.02% | 126 |
|